CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Matilda Kråkström - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Matilda Kråkström

OPENALEX: A5080502477↗ORCID: 0000-0001-7956-958X↗

Affiliations

Organizations

Åbo Akademi Universityauthorship · FI Turku Centre for Computer Scienceauthorship · FI University of Turkuauthorship · FI

Public evidence

3 connected articles

Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.2025 · Europe PMC Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD).2024 · Europe PMC Dynamics of the Lipidome in a Colon Simulator.2023 · Europe PMC

Registered research

Connected studies

Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Studynct04605393 Pharmacokinetic Study of a Novel Lipid Formulation of Cannabidiol Compared to a Standard Formulationnct05032807

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.